HER2 over-expression is not restricted to a subset of mammary gland tumors since it is also over-expressed in mammary tumors from other subtypes, like basal, luminal A, or luminal B breast tumors (Figure 2A), as well as in a small fraction of other tumor types (Figure 2B). Here, ERBB2 is linked to breast neoplasm.